Literature DB >> 15680465

Growth-promoting effect of platelet-derived growth factor on rat cardiac myocytes.

Jie Liu1, Li-ling Wu, Li Li, Liang Zhang, Zong-En Song.   

Abstract

Platelet-derived growth factor (PDGF) is a dimeric molecule consisting of disulfide-bonded A- and B-polypeptide chains. Homodimeric (PDGF-AA, PDGF-BB) as well as heterodimeric (PDGF-AB) isoforms exert their effects on target cells by binding with different specificities to two structurally related protein tyrosine kinase receptors, denoted alpha- and beta-receptors. PDGF stimulates growth in various cell types, but little is known about its effect on mammalian cardiomyocytes. Therefore, growth-promoting effect of PDGF on rat cardiomyocytes was investigated. Primary culture of neonatal rat ventricular myocytes was prepared and cellular growth was estimated by [3H]-leucine incorporation assay. Tyrosine-phosphorylated PDGF-beta receptor of cardiomyocytes was determined by immunoblotting analysis after immunoprecipitation. PDGF-beta receptor, extracellular signal-regulated kinase (ERK) 1/2 and phosphorylated ERK1/2 of cardiomyocytes were measured by immunoblotting analysis. [3H]-leucine incorporation into the cultured myocytes was increased in a time- and dose-dependent manner after PDGF-BB stimulation. Phosphorylation of PDGF-beta receptor and ERK1/2 in cardiomyocytes was increased after short-term stimulation of PDGF-BB. Protein expression of PDGF-beta receptor and ERK1/2 was increased after long-term stimulation of PDGF-BB. [(3)H]-leucine incorporation into the cultured myocytes induced by PDGF-BB was partly blocked by mitogen-activated ERK-activating kinase (MEK) inhibitor PD98059, phospholipase C (PLC) inhibitor U73122, and protein kinase C (PKC) inhibitor staurosporin aglycone, respectively. Therefore, PDGF beta receptor, ERK1/2, PLC and PKC are involved in the signal transduction of PDGF-induced growth response of rat cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15680465     DOI: 10.1016/j.regpep.2004.10.018

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  4 in total

Review 1.  Adverse effects of anticancer agents that target the VEGF pathway.

Authors:  Helen X Chen; Jessica N Cleck
Journal:  Nat Rev Clin Oncol       Date:  2009-07-07       Impact factor: 66.675

Review 2.  Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer.

Authors:  Aleksandra Grela-Wojewoda; Renata Pacholczak-Madej; Agnieszka Adamczyk; Michał Korman; Mirosława Püsküllüoğlu
Journal:  Int J Mol Sci       Date:  2022-03-04       Impact factor: 5.923

3.  Mechanism underlying increased cardiac extracellular matrix deposition in perinatal nicotine-exposed offspring.

Authors:  Tsai-Der Chuang; Aamir Ansari; Celia Yu; Reiko Sakurai; Amir Harb; Jie Liu; Omid Khorram; Virender K Rehan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-08-14       Impact factor: 5.125

4.  SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition.

Authors:  Zhuqing Jia; Jiaji Wang; Qiong Shi; Siyu Liu; Weiping Wang; Yuyao Tian; Qin Lu; Ping Chen; Kangtao Ma; Chunyan Zhou
Journal:  Apoptosis       Date:  2016-02       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.